Clinical Trial Update: Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating MNK-155 for postsurgical acute pain in adolescents has been withdrawn, with the report focusing on pharmacokinetics and safety consid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• MNK-155

Snippet

Sponsor: Mallinckrodt | Conditions: Acute Pain | Phase 1 | Status: WITHDRAWN